CAT No: CP25556
CAS No:200616-39-3
Synonyms/Alias:200616-39-3;Fmoc-L-Glu(2-phenylisopropyloxy)-OH;Fmoc-Glu(O-2-PhiPr)-OH;Fmoc-Glu(2-phenylisopropyl ester)-OH;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-(2-phenylpropan-2-yloxy)pentanoic acid;(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-((2-phenylpropan-2-yl)oxy)pentanoic acid;Fmoc-Glu(OPp)-OH;Fmoc-Glu(O-2-PhiPr)-OH;Fmoc-Glu(OPis)-OH;Fmoc-L-Glu(O-2-PhiPr)-OH;DTXSID40718516;AKOS016014561;FD21498;HY-W141945;AS-49095;CS-0201735;Fmoc-L-glutamic acid 5-(2-phenylisopropyl) ester;Fmoc-L-glutamic acid-gamma-2-phenylisopropyl ester;N-Fmoc-L-glutamic acid 5-(2-phenyl-2-propyl) ester;S-200616-39-3;(2S)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-5-oxo-5-[(2-phenylpropan-2-yl)oxy]pentanoic acid;(2S)-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}-5-OXO-5-[(2-PHENYLPROPAN-2-YL)OXY]PENTANOIC ACID;
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-glutamic acid beta-(2-phenylisopropyl ester)
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.